Results overview: Found 3 records in 0.02 seconds.
Articles, 3 records found
Articles 3 records found  
1.
9 p, 1.5 MB Real-life experience with 4 years of golimumab persistence in ulcerative colitis patients / Iborra, Marisa (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; García-Morales, Natalia (Hospital Universitari i Politècnic La Fe (València)) ; Rubio, Saoia (Complejo Hospitalario de Navarra) ; Bertoletti, Federico (Institut d'Investigació Biomèdica Sant Pau) ; Calvo, Marta (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Taxonera, Carlos (Hospital Clínico San Carlos (Madrid)) ; Boscá-Watts, Marta Maia (Hospital Clínico Universitario) ; Sierra, Mónica (Complejo Asistencial Universitario de León) ; Manceñido, Noemí (Hospital Universitario Infanta Sofía (San Sebastián de los Reyes)) ; Beltrán, Belén (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Nantes Castillejo, Óscar (Complejo Hospitalario de Navarra) ; García-Planella, Esther (Institut d'Investigació Biomèdica Sant Pau) ; Vera, Isabel (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Alba, Cristina (Hospital Clínico San Carlos (Madrid)) ; Martí-Aguado, DavidHospital Clínico Universitario ; Ballester, María Pilar (Hospital Clínico Universitario) ; Cano-Sanz, Noelia (Complejo Asistencial Universitario de León) ; Pajares-Villarroya, Ramón (Hospital Universitario Infanta Sofía (San Sebastián de los Reyes)) ; Cerrillo, Elena (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Cañada, Antonio (Instituto de Investigación Sanitaria Hospital Universitario y Politécnico La Fe) ; Nos, Pilar (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas) ; Universitat Autònoma de Barcelona
Golimumab has demonstrated its long-term efficacy and safety in ulcerative colitis in clinical trials, but no data of long-term persistence has been published from real world. To estimate long-term persistence of golimumab, as well as factors associated with longer persistence, in patients with ulcerative colitis in real life. [...]
2020 - 10.1038/s41598-020-73577-0
Scientific reports, Vol. 10 Núm. 1 (january 2020) , p. 17774  
2.
11 p, 519.8 KB Prevalence and clinical impact of alcohol withdrawal syndrome in alcohol-associated hepatitis and the potential role of prophylaxis : a multinational, retrospective cohort study / Marti-Aguado, David (Institut d'Investigació Biomèdica (INCLIVA)) ; Gougol, Amir (University of California) ; Gomez-Medina, Concepcion (Institut d'Investigació Biomèdica (INCLIVA)) ; Jamali, Arsia (University of Pittsburgh Medical Center) ; Abo-Zed, Abdelrhman (University of Pittsburgh Medical Center) ; Morales-Arraez, Dalia (Hospital Universitario de Canarias (La Laguna)) ; Jimenez-Sosa, Alejandro (Hospital Universitario de Canarias (La Laguna)) ; Burns, Keith (University of Pittsburgh Medical Center) ; Bawa, Aditi (University of Pittsburgh Medical Center) ; Hernández, Anjara (Hospital Universitario de Canarias (La Laguna)) ; Pujol, Claudia (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Alvarado-Tapias, Edilmar (Institut d'Investigació Biomèdica Sant Pau) ; Szafranska, Justyna (Institut d'Investigació Biomèdica Sant Pau) ; Chiu, Wai Kan (University of Pittsburgh Medical Center) ; Villagrasa, Ares (Hospital Universitari Vall d'Hebron) ; Ventura-Cots, Meritxell (Hospital Universitari Vall d'Hebron) ; Gandicheruvu, Haritha (University of Pittsburgh Medical Center) ; Lluch, Paloma (Institut d'Investigació Biomèdica (INCLIVA)) ; Chen, Hui-Wei (Allegheny General Hospital) ; Rachakonda, Vikrant (University of California) ; Duarte-Rojo, Andres (University of Pittsburgh Medical Center) ; Bataller, Ramon (Hospital Clínic i Provincial de Barcelona) ; Universitat Autònoma de Barcelona
The prevalence and impact of alcohol withdrawal syndrome (AWS) in patients with alcohol-associated hepatitis (AH) are unknown. In this study, we aimed to investigate the prevalence, predictors, management, and clinical impact of AWS in patients hospitalized with AH. [...]
2023 - 10.1016/j.eclinm.2023.102046
EClinicalMedicine, Vol. 61 (june 2023)  
3.
12 p, 1022.2 KB Bariatric Surgery Is Associated with Alcohol-Related Liver Disease and Psychiatric Disorders Associated with AUD / Alvarado-Tapias, Edilmar (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Marti-Aguado, David (Institut d'Investigació Biomèdica INCLIVA) ; Kennedy, Kevin (Kansas City) ; Fernández-Carrillo, Carlos (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Ventura-Cots, Meritxell (Hospital Universitari Vall d'Hebron) ; Morales-Arraez, Dalia (Hospital Universitario de Canarias (La Laguna)) ; Atkinson, Stephen R. (Imperial College London) ; Clemente-Sanchez, Ana (Hospital General Universitario Gregorio Marañón) ; Argemi, Josepmaria (Clínica Universidad de Navarra) ; Bataller, Ramon (Universitat de Barcelona) ; Universitat Autònoma de Barcelona
Bariatric surgery can increase the risk of addictive disorders and nutritional deficiencies. The aim of this study was to evaluate the association between bariatric surgery and alcohol use disorder (AUD), alcohol-related liver disease (ALD), and psychiatric disorders associated with AUD. [...]
2023 - 10.1007/s11695-023-06490-w
Obesity Surgery, Vol. 33 (march 2023) , p. 1494-1505  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.